Top

BMC Cardiovascular Disorders

Published in:

Open Access 01-12-2020 | Stable Angina Pectoris | Research article

P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study

Authors: Li Shen, Tianlun Yang, Ke Xia, Zhiqiang Yan, Juanjuan Tan, Lei Li, Yingchun Qin, Wei Shi

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Abstract

Background

Platelet activation plays a crucial role in the pathogenesis of coronary artery disease (CAD). Platelet P-selectin (CD62P) is a classic platelet activation indicator on the platelet surface, and soluble TREM-like transcript-1 (sTLT-1) is a new indicator. However, the relationship between these two markers and CAD, especially in acute coronary syndrome (ACS), has not been elucidated. This study aimed to investigate CD62P expression on the platelet surface and sTLT-1 expression in serum, as well as to assess their relationship with CAD.

Methods

We measured the levels of CD62P and sTLT-1 in 83 patients with CAD compared to 49 controls. The association of these indicators with age, blood pressure, lipid profile, body mass index, and liver injury marker level were also examined.

Results

CD62P concentration was higher in CAD patients than in the control group (P < 0.01), especially in acute myocardial infarction (AMI) patients (P < 0.01). Serum sTLT-1 concentration was higher in the AMI and unstable angina pectoris (UAP) groups than in the normal control (NC) group (P < 0.01).

Conclusions

The consistency of sTLT-1 and CD62P expression levels in CAD patients indicates that sTLT-1 level, the same as CD62P, may be a new marker of platelet activation that is positively related to CAD.

Available only for authorised users

Grande P, Grauholt AM, Madsen JK. Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation. 1990;81(1 Suppl):I16–9 I22-3 https://pubmed.ncbi.nlm.nih.gov/2136815/.PubMed

Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med. 2000;191(8):1413–22. https://doi.org/10.1084/jem.191.8.1413https://pubmed.ncbi.nlm.nih.gov/10770806/.CrossRefPubMedPubMedCentral

George R, Bhatt A, Narayani J, Thulaseedharan JV, Sivadasanpillai H, Tharakan JA. Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease. Mol Cell Biochem. 2016;419(1–2):125–33. https://doi.org/10.1007/s11010-016-2756-4https://pubmed.ncbi.nlm.nih.gov/27406211/.CrossRefPubMed

Tenaglia AN, Buda AJ, Wilkins RG, Barron MK, Jeffords PR, Vo K, et al. Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris. Am J Cardiol. 1997;79(6):742–7. https://doi.org/10.1016/s0002-9149(96)00861-2https://pubmed.ncbi.nlm.nih.gov/9070552/.CrossRefPubMed

Washington AV, Schubert RL, Quigley L, Disipio T, Feltz R, Cho EH, et al. A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets. Blood. 2004;104(4):1042–7. https://doi.org/10.1182/blood-2004-01-0315https://pubmed.ncbi.nlm.nih.gov/15100151/.CrossRefPubMed

Washington AV, Quigley L, McVicar DW. Initial characterization of TREM-like transcript (TLT)-1: a putative inhibitory receptor within the TREM cluster. Blood. 2002;100(10):3822–4. https://doi.org/10.1182/blood-2002-02-0523https://pubmed.ncbi.nlm.nih.gov/12393607/.CrossRefPubMed

Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol. 2012;188(11):5585–92. https://doi.org/10.4049/jimmunol.1102674https://pubmed.ncbi.nlm.nih.gov/22551551/.CrossRefPubMedPubMedCentral

Koh TW, DeSouza AC, Pepper JR. The adhesion molecule P-selectin and cardiovascular disease--cardiac surgical implications. Eur Heart J. 2004;25(11):993. https://doi.org/10.1016/j.ehj.2004.01.023https://pubmed.ncbi.nlm.nih.gov/15172472/.CrossRefPubMed

Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420(6917):885–91. https://doi.org/10.1038/nature01326https://pubmed.ncbi.nlm.nih.gov/12490963/.CrossRefPubMed

10.

Jolly L, Lemarie J, Carrasco K, Popovic B, Derive M, Boufenzer A, et al. Triggering receptor expressed on myeloid cells-1: a new player in platelet aggregation. Thromb Haemost. 2017;117(9):1772–81. https://doi.org/10.1160/TH17-03-0156https://pubmed.ncbi.nlm.nih.gov/28837205/.CrossRefPubMed

11.

Geng JG, Chen M, Chou KC. P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem. 2004;11(16):2153–60. https://doi.org/10.2174/0929867043364720https://pubmed.ncbi.nlm.nih.gov/15279555/.CrossRefPubMed

12.

Esponda OL, Hunter R, Del RJ, Washington AV. Levels of soluble TREM-like transcript 1 in patients presenting to the emergency department with chest pain. Clin Appl Thromb Hemost. 2015;21(1):30–4. https://doi.org/10.1177/1076029614547298https://pubmed.ncbi.nlm.nih.gov/25147325/.CrossRefPubMed

13.

Morales-Ortiz J, Rondina MT, Brown SM, Grissom C, Washington AV. High levels of soluble triggering receptor expressed on myeloid cells-like transcript (TLT)-1 are associated with acute respiratory distress syndrome. Clin Appl Thromb Hemost. 2018;24(7):1122–7. https://doi.org/10.1177/1076029618774149https://pubmed.ncbi.nlm.nih.gov/29758998/.CrossRefPubMedPubMedCentral

14.

Senis YA. TLT-1: please release me, let me go. Blood. 2018;132(23):2427–9. https://doi.org/10.1182/blood-2018-10-879676https://pubmed.ncbi.nlm.nih.gov/30523125/.CrossRefPubMed

15.

Fu R, Song X, Su D, Li S, Gao L, Ji C. Serum STLT-1 and bilirubin levels in patients with acute coronary syndrome and correlation with prognosis. Exp Ther Med. 2018;16(1):241–5. https://doi.org/10.3892/etm.2018.6137https://pubmed.ncbi.nlm.nih.gov/29977364/.CrossRefPubMedPubMedCentral

Title: P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study
Authors: Li Shen
Tianlun Yang
Ke Xia
Zhiqiang Yan
Juanjuan Tan
Lei Li
Yingchun Qin
Wei Shi
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Stable Angina Pectoris
Myocardial Infarction
Acute Coronary Syndrome
Unstable Angina
Arterial Diseases
Published in: BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-020-01663-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Comparison of morphometry and ventricular function of healthy and smoking young people

Cardiovascular risk factor mapping and distribution among adults in Mukono and Buikwe districts in Uganda: small area analysis

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome

A novel TAB2 nonsense mutation (p.S149X) causing autosomal dominant congenital heart defects: a case report of a Chinese family

Pelvic collateral pathway during endovascular aortoiliac aneurysm repair with internal iliac artery interruption: a retrospective observational study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page